trial · primary record
PF-07868489
Pulmonary Hypertension
| Phase | Phase 2 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 42 |
| Primary completion | 2026-10-09 |
| Primary endpoint | Number of Participants with Treatment Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs) |
| Registry ID | NCT07073820 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:07.286Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07073820
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.